Press Releases
60-person clinical trial to investigate therapeutic device as an alternative to opioids following sinus surgeries SAN FRANCISCO, January 19, 2022 – Tivic Health® Systems, Inc., (Nasdaq: TIVC), a commercial-phase healthtech company focused on bioelectronic medicine, today announced initiation of its second clinical study investigating the extension of the company’s bioelectronic platform, offering a potentially new […]
SAN FRANCISCO, December 20, 2021 – Tivic Health Systems, Inc. (Nasdaq: TIVC), an emerging growth company focused on non-invasive bioelectronic medicine, names Mindgruve, a modern marketing agency, as its digital marketing agency of record. Mindgruve will work with Tivic Health to develop an integrated marketing and brand strategy that supports marketing and sales efforts in […]
SAN FRANCISCO, December 8, 2021 – Tivic Health Systems, Inc. (Nasdaq: TIVC), an emerging growth company focused on non-invasive bioelectronic medicine, has been named to Fast Company’s inaugural Next Big Things in Tech 2021 honoring the technology breakthroughs that promise to shape the future of their industries—from healthcare to agriculture to artificial intelligence and more. […]
SAN FRANCISCO, December 6, 2021 – Tivic Health Systems, Inc. (Nasdaq: TIVC), a commercial-phase bioelectronic medicine company, today announced that CEO Jennifer Ernst will present a corporate overview at the Sidoti Micro Cap Conference taking place virtually, December 8-9, 2021. Ms. Ernst is scheduled to discuss the rapidly growing field of bioelectronic medicine and will […]
MENLO PARK, CA, November 15, 2021– Tivic Health Systems, Inc. (Nasdaq: TIVC) (“Tivic” or the “Company”), a commercial-phase bioelectronic medicine company, today announced the closing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per share for gross proceeds of $15,000,000 before deducting underwriting discounts […]
Menlo Park, CA, November 10, 2021 — Tivic Health Systems, Inc. (Nasdaq: TIVC) (“Tivic” or the “Company”), a commercial-phase bioelectronic medicine company, today announced the pricing of its initial public offering of 3,000,000 shares of its common stock at a public offering price of $5.00 per share, for gross proceeds of $15,000,000, before deducting underwriting […]
September 9, 2021 – Tivic Health Systems, which makes a non-invasive neuromodulation device for sinus and nasal inflammation, announced terms for its IPO on Thursday. The Newark, CA-based company plans to raise $15 million by offering 2.7 million shares at a price range of $5 to $6. At the midpoint of the proposed range, Tivic […]
ClearUP’s FDA De Novo Request Grant Breaks New Ground With Use of Microcurrent to Provide Congestion Relief From Colds, Flu, Allergies San Francisco, April 19, 2021 – It’s spring allergy season and 50 million allergy sufferers are looking for relief from congestion and allergy-related sinus pain. Tivic Health® Systems Inc., a first-in-class bioelectronic health device company, developed […]
Helping Millions Through Bioelectronics Without Medication San Francisco, March 24, 2021 – Tivic Health® Systems Inc., a first-in-class developer of bioelectronics health devices, today announced that the U.S. Food and Drug Administration (FDA) has expanded the indication for use of ClearUP® Sinus Pain Relief to include congestion from allergies, the flu, and the common […]
San Francisco, November 17, 2020 – Tivic Health® Systems Inc., today announced that Michael B. Foggs, MD, FAAAAI, DFACAAI, FCCP, and chief of allergy and immunology at Advocate Medical Group of AdvocateAuroraHealth in Chicago has joined the company’s Medical Advisory Board. Dr. Foggs joins the Tivic Health Medical Advisory Board that includes: Subinoy Das, MD, […]
